| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/20/2009 | US7605316 Plants and seeds of hybrid corn variety CH820648 |
| 10/20/2009 | US7605313 Plants and seeds of corn variety CV590239 |
| 10/20/2009 | US7605312 Plants and seeds of corn variety CV971868 |
| 10/20/2009 | US7605311 Plants and seeds of hybrid corn variety CH407425 |
| 10/20/2009 | US7605310 Inbred corn line BC5 |
| 10/20/2009 | US7605304 Obtained from mutagenic strains of Bacillus thuringiensis encoding endotoxins |
| 10/20/2009 | US7605303 cloning a rice stress-responsive gene, RSI, using the isolated gene to breed NaCl and drought resistance plant but not resistance to abscisic acid; genetic engineering |
| 10/20/2009 | US7605253 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 10/20/2009 | US7605248 Recombinant constructs of Borrelia burgdorferi |
| 10/20/2009 | US7605247 Nucleic acid molecules encoding a wheat sucrose transporter |
| 10/20/2009 | US7605246 Genes differentially expressed in breast cancer |
| 10/20/2009 | US7605245 PUFA polyketide synthase systems and uses thereof |
| 10/20/2009 | US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 10/20/2009 | US7605233 Tumour necrosis factor binding ligands |
| 10/20/2009 | US7605232 Hydrogels for protein concentration |
| 10/20/2009 | US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane |
| 10/20/2009 | US7605229 Chimera; FC fragments; antibody overexpression; immunoglobulins; gene therapy |
| 10/20/2009 | US7605228 Insecticidal toxin complex fusion proteins |
| 10/20/2009 | US7605226 Meltrins |
| 10/20/2009 | US7605142 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 10/20/2009 | US7605140 Endothelial growth factors; antiischemic agents; neovascularization |
| 10/20/2009 | US7605133 Isolated peptides to treat alpha-synuclein diseases |
| 10/20/2009 | US7605129 Splice variant of human placental growth hormone |
| 10/20/2009 | US7605127 Truncated hepatocyte growth factor variant protein HGF/NK2 |
| 10/20/2009 | US7605122 sublingual formulations for promoting weight loss in a human on low caloric diet ,comprising reconstituted hCG, having a pH in the range of about 7.0 to 8.0, sodium carbonate buffer, an absorption-enhancing compound (corn oil, mineral oil), and a taste-enhancing agent (glycerin) |
| 10/20/2009 | US7605003 Using apolipoprotein A1 (Apo A1), a truncated form of transthyretin, ("transthyretin Delta N10) and/or a cleavage fragment of inter- alpha -trypsin inhibitor heavy chain H4 (IAIH4 fragment) as diagnostic/prognostic indicators of cell proliferative disorders of urogenital systems |
| 10/20/2009 | US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector |
| 10/20/2009 | US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity |
| 10/20/2009 | US7604982 High-throughput screening method for intergrin antagonist and new peptide screened therefrom |
| 10/20/2009 | US7604972 Nicotianamine synthase |
| 10/20/2009 | US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus |
| 10/20/2009 | US7604961 VP1 of foot-and-mouth disease virus |
| 10/20/2009 | US7604959 Cell-based assays employing voltage and calcium dyes |
| 10/20/2009 | US7604944 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 10/20/2009 | US7604931 Cripto mutant and uses thereof |
| 10/20/2009 | US7604824 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent |
| 10/20/2009 | US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability |
| 10/20/2009 | US7604810 Conserved Neisserial antigens |
| 10/20/2009 | US7604808 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/20/2009 | CA2359667C Method of identifying n-terminal probnp |
| 10/20/2009 | CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 10/20/2009 | CA2330183C Novel insulin analogs with enhanced zinc binding |
| 10/20/2009 | CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use |
| 10/20/2009 | CA2227467C Helper virus-free herpesvirus vector packaging system |
| 10/15/2009 | WO2009126896A2 Methods and compositions for root knot nematode control |
| 10/15/2009 | WO2009126725A1 Method of modulating neovascularization |
| 10/15/2009 | WO2009126719A2 Commensal bacteria as signal mediators within a mammalian host |
| 10/15/2009 | WO2009126688A2 Novel compositions and methods for the treatment of immune related diseases |
| 10/15/2009 | WO2009126648A1 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
| 10/15/2009 | WO2009126292A2 Biologically active peptidomimetic macrocycles |
| 10/15/2009 | WO2009126208A2 Heat resistant plants and plant tissues and methods and materials for making and using same |
| 10/15/2009 | WO2009126031A1 Recombinant protein enriched in a heparin binding site and/or a heparan sulfate binding site |
| 10/15/2009 | WO2009125925A2 Growth factor-mimicking peptides and uses thereof |
| 10/15/2009 | WO2009125826A1 Gene capable of being expressed specifically in endosperm of plant, promoter for the gene, and use of the gene and the promoter |
| 10/15/2009 | WO2009125646A1 Tdp-43-storing cell model |
| 10/15/2009 | WO2009125607A1 Apoptosis inducer |
| 10/15/2009 | WO2009125424A2 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
| 10/15/2009 | WO2009124948A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases |
| 10/15/2009 | WO2009124932A1 Peptides for inhibiting the hpv-e6 oncoprotein |
| 10/15/2009 | WO2009124670A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing |
| 10/15/2009 | WO2009124503A1 Use of protein extract from plant seed embryo and composition thereof |
| 10/15/2009 | WO2009124362A1 Suppressor of the endogenous interferon- gamma |
| 10/15/2009 | WO2009124353A1 Modified cpn10 and prr signalling |
| 10/15/2009 | WO2009124333A1 Modified chaperonin 10 and prr signaling |
| 10/15/2009 | WO2009104188A3 Photoactive nanostructure and method of manufacturing same |
| 10/15/2009 | WO2009094636A3 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 10/15/2009 | WO2009092113A3 Methods and compositions for the delivery of vaccines to disrupted epithelium |
| 10/15/2009 | WO2009083958A8 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 10/15/2009 | WO2009081136A3 Screening |
| 10/15/2009 | WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site |
| 10/15/2009 | WO2009077744A3 Vaccines for brucellosis |
| 10/15/2009 | WO2009074271A8 Peptides modulators of tubulin polymerisation |
| 10/15/2009 | WO2009071914A3 Mutant proteins and methods for producing them |
| 10/15/2009 | WO2009044158A3 Inhibitors and uses |
| 10/15/2009 | WO2008151078A9 Methods and compositions for modulating bmp-10 activity |
| 10/15/2009 | US20090260109 Methods of increasing abiotic stress tolerance and/or biomass in plants genterated thereby |
| 10/15/2009 | US20090260107 Coleopteran-Resistant Transgenic Plants and Methods of Their Production |
| 10/15/2009 | US20090260101 Heat resistant plants and plant tissues and methods and materials for making and using same |
| 10/15/2009 | US20090260095 Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same |
| 10/15/2009 | US20090260091 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders; Ccr2-deficient mice; drug screening |
| 10/15/2009 | US20090259028 Prevention of leaching of ligands from affinity-based purification systems |
| 10/15/2009 | US20090259025 Lactoferrin |
| 10/15/2009 | US20090259024 recombination; sensors |
| 10/15/2009 | US20090259023 Liquid buffered gdf-5 formulations |
| 10/15/2009 | US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 10/15/2009 | US20090259021 Liquid Phase Peptide Synthesis of KL-4 Pulmonary Surfactant |
| 10/15/2009 | US20090259019 Masp-2, a complement fixing enzyme, and uses for it |
| 10/15/2009 | US20090258834 Plasma protein-binding ligands |
| 10/15/2009 | US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity |
| 10/15/2009 | US20090258827 Transcription Factor Modulator |
| 10/15/2009 | US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 10/15/2009 | US20090258825 HOPM1 Mediated disease resistance to Pseudomonas syringae in Arabidopsis |
| 10/15/2009 | US20090258819 Reagents and Methods for Smooth Muscle Therapies |
| 10/15/2009 | US20090258818 Compositions For the Treatment of Diabetes |
| 10/15/2009 | US20090258426 Preferred segments of neural thread protein and method of using the same |
| 10/15/2009 | US20090258424 Cellular Delivery of siRNA |
| 10/15/2009 | US20090258420 Altered polypeptides, immunoconjugates thereof, and methods related thereto |
| 10/15/2009 | US20090258409 Purified sr-p70 protein |
| 10/15/2009 | US20090258400 Mutant Tyrosine Repressor, a Gene Encoding the Same, and a Method for Producing L-Dopa |
| 10/15/2009 | US20090258396 Crustaceans as production systems for therapeutic proteins |